Form 4: NeuroOne Medical Technologies Corp: Officer Reports Stock Disposal for Tax Obligations

Mark Christianson, Business Development Director at NeuroOne Medical Technologies Corp, disposed of 90 shares of common stock on January 31, 2025, to cover tax obligations.

Summary

• On January 31, 2025, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 90 shares of common stock.
• The transaction was executed at a price of $1.15 per share.
• The disposal was related to covering tax obligations.
• Following the transaction, Christianson directly owns 293,556 shares of NeuroOne Medical Technologies Corp.
• The form was signed on February 4, 2025, by Stephanie Swan under Power of Attorney.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions by an insider. It doesn't convey any particularly positive or negative sentiment about the company's performance or prospects.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who transact in their company's stock. It provides transparency into the trading activities of individuals with access to non-public information.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders, as it involves a small number of shares.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Disposal, NeuroOne Medical Technologies, NMTC, Mark Christianson, Insider Trading